Prosecution Insights
Last updated: August 18, 2026
Application No. 18/827,457

ULTRASOUND DIAGNOSTIC APPARATUS AND CONTROL METHOD OF ULTRASOUND DIAGNOSTIC APPARATUS

Non-Final OA §103§112
Filed
Sep 06, 2024
Priority
Sep 28, 2023 — JP 2023-167690
Examiner
ROBINSON, NICHOLAS A
Art Unit
3798
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Fujifilm Holdings Corporation
OA Round
3 (Non-Final)
49%
Grant Probability
Moderate
3-4
OA Rounds
1y 6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
71 granted / 146 resolved
-21.4% vs TC avg
Strong +58% interview lift
Without
With
+58.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
41 currently pending
Career history
196
Total Applications
across all art units

Statute-Specific Performance

§101
11.4%
-28.6% vs TC avg
§103
40.8%
+0.8% vs TC avg
§102
14.5%
-25.5% vs TC avg
§112
30.2%
-9.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 146 resolved cases

Office Action

§103 §112
DETAILED ACTION This Office action is responsive to communications filed on 05/26/2026. Claims 1, 3, 6, 9-12, 14-15, & 20 have been amended. Claims 2 & 4 are canceled. Presently, Claims 1, 3, & 5-20 remain pending and are hereinafter examined on the merits. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 05/26/2026 has been entered. Response to Arguments Previous claim objections are withdrawn in view of the amendments filed on 05/26/2026. In the previous office action filed on 03/23/2026, the following was indicated, “Previous rejections under 35 USC § 112(b) are withdrawn in view of the amendments filed on 11/13/2025 except for Claim 6 and Claims 9-12.” Similarly, previous rejections under 35 USC § 112(b) are withdrawn in view of the amendments filed on 05/26/2026 except for Claim 6. As such, it does not appear that the 35 USC § 112(b) issues are corrected. Correction is required of the following maintained 35 USC § 112(b) is needed: “Claim 6: line 5-6, it is unclear what once determining the noncontact state, determine whether the non-depicted portion is present means in the context of the claim. The claimed phrase appears grammatically incomplete. In addition, if the probe is not in contact, no ultrasound image can be acquired, and thus no-image-based analysis such as (‘non-depicted portion) can be performed. Accordingly, the claim is meet if a system detects a condition in which the ultrasound is not physically in contact with the subject’s body surface. Appropriate correction is required.” The Applicant’s arguments with respect to rejections under 35 USC § 103 have been fully, considered, but are not persuasive. The Applicant arguments do not overcome the current rejection. Evaluating the claims at face value, the change from "image representing a three-dimensional shape of the contour and an image representing a three-dimensional shape of the region in a superimposed manner in different displaying manner" does not narrower the scope or change the scope of "a first image representing a three-dimensional shape of the contour and a second image representing a three-dimensional shape of the region in different displaying manners such that a user can ascertain both the first image and the second image," An image representing a three-dimensional shape of the contour would still constitutes as a first image. An image representing a three-dimensional shape of the contour would still constitutes as a second image. The prior art would also teach a user can ascertain both the first image and the second image because otherwise there would be no purpose of obtaining the two images. Specifically, the premise of the prior art Orlando is to ascertain these images, otherwise there would be no results or purpose of the investigation taught by Orlando, FIG. 4-6. In addition, the feature of "such that a user can ascertain both the first image and second image" is merely the intended result/desire/use. Ascertaining images is a known concept in the prior arts as taught by Orlando. The Applicant’s heavy reliance on a narrower interpretation is not reflected in the claims, and thus not persuasive. Therefore, 35 USC 103 rejection is maintained. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 6, & 12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as failing to set forth the subject matter which the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the applicant regards as the invention. Claim 6: line 5-6, it is unclear what once determining the noncontact state, determine whether the non-depicted portion is present means in the context of the claim. The claimed phrase appears grammatically incomplete. In addition, if the probe is not in contact, no ultrasound image can be acquired, and thus no-image-based analysis such as (‘non-depicted portion) can be performed. Accordingly, the claim is meet if a system detects a condition in which the ultrasound is not physically in contact with the subject’s body surface. Appropriate correction is required. line 3, "an ultrasound image". It is unclear if the ultrasound image refers to or is separate from the ultrasound image. Consistent claim language is required by the claim. For examination purposes, the Examiner assumes an ultrasound image of the plurality of ultrasound images. Appropriate correction is needed. The dependent claims of the above rejected claims are rejected due to their dependency. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 3, 5-15, 17, and 19-20 are rejected under 35 U.S.C. 103 as being unpatentable over Fujisawa (US 2021/0093303 A1) in view of Orlando et al (Automatic prostate segmentation using deep learning on clinically diverse 3D transrectal ultrasound images. Med Phys. 2020 Jun). Claim 1: Fujisawa discloses, An ultrasound diagnostic apparatus comprising: (¶Abstract, FIG. 3) a monitor; (display 20, FIG. 3) an ultrasound probe; (ultrasonic probe 30, FIG. 3) a position and posture sensor that acquires position and posture information of the ultrasound probe; and (position sensor 40, FIG. 3, ¶0053) a processor configured to: (¶0079, ‘image processor 30’) acquire a plurality of ultrasound images of a subject by transmitting and receiving ultrasound beams by using the ultrasound probe; (¶Abstract, ¶0026-0027, ¶0077) generate three-dimensional image data of a contour of an organ included in each of the plurality of ultrasound images based on the position and posture information acquired by the position and posture sensor; generate three-dimensional image data of a region of the organ included in each of the plurality of ultrasound images based on the position and posture information acquired by the position and posture sensor; and -The ultrasonic image data, in the form of multiple cross-sections, correspond to position data of the ultrasonic probe, ¶0061-0063, ¶0103-0104. This positional data includes the coordinates (X, Y, Z) and tilt angle (posture) of the probe, ¶0054. The acquired ultrasonic image is arranged three-dimensionally in a 3D memory based on the position data, ¶0078-0080, ¶0103-0104. From this collection of three-dimensionally arrange ultrasonic image data and position data, deriving function 172 determines the shape of the entire target organ and the imaged organ region, ¶0076-0077, ¶0082, ¶0107. The determining function 172 specifically extracts an organ contour from the ultrasonic image of cross-sections arranged three-dimensionally, ¶0108. This extracted organ contour is then arranged in a three-dimensional manner, ¶0108, and thus the region of the organ is arranged in a three-dimensional manner. This volume data of the 3D image data represents the imaged organ region in three-dimensions, ¶0076-0077, ¶0082, ¶0107. Fujisawa fails to disclose: display, on the monitor, a first image representing a three-dimensional shape of the contour and a second image representing a three-dimensional shape of the region in different displaying manners, such that a user can ascertain both the first image and the second image, based on the three-dimensional image data of the contour and the three-dimensional image data of the region, wherein the three-dimensional image data of the contour and the three-dimensional image data of the region are generated independently of each other. However, Orlando in the context of segmentation techniques using deep learning on ultrasound images discloses, display, on the monitor, a first image representing a three-dimensional shape of the contour and a second image representing a three-dimensional shape of the region in different displaying manners, such that a user can ascertain both the first image and the second image, based on the three-dimensional image data of the contour and the three-dimensional image data of the region, -Regarding the region, Orlando teaches 3D TRUS images serving as the 3D region data acquired from the patient, [2.A Clinical dataset / pg. 2415], ‘Three-dimensional images of the prostate were acquired using end-fire (as used in prostate biopsy) and side-fire SR (as used in some HDR-BT) mechanical scanning approaches (Fig. 1).19 Both methods rotate a TRUS transducer around the long-axis to create geometrically different reconstructed 3D images that are influenced by the transducer array configuration. The images used in this study were acquired with the C9-5 transducer with the iU22 (Philips, Amsterdam, the Netherlands), the C9-5 and BPTRT9-5 transducers with the ATL HDI-5000 (Philips, Amsterdam, the Netherlands), and the 8848 transducer with the Profocus 2202 (BK Medical, Peabody, MA, USA) ultrasound machine models. The total dataset of 246 3D TRUS images consisted of 104 end-fire and 142 side-fire 3D TRUS images and was split into training, validation, and testing datasets as shown in Table I. Manual 3D prostate segmentations (excluding the seminal vesicles) were performed by an observer (IG) with approximately 15 yr of TRUS prostate image analysis experience.’ -Regarding the 3D image contour (i.e., boundary) is generated entirely independent of the raw region data. It is generated manually by an observer with 15 years of experience or computationally via deep learning, such as U-Net or 3D V-NET, see [2.A Clinical dataset / pg. 2415], [2.B.3. 3D Reconstruction / pg 2416], ‘2.B.3 3D Reconstruction Predicted 3D prostate segmentations were obtained by segmenting multiple 2D radial frames generated by rotation around a central axis, followed by reconstruction to a 3D surface following a reconstruction method similar to Qiu et al.11 Previous observations have noted that segmenting the prostate on slices near the apex and base of the prostate can be challenging due to boundary incompleteness,15 so we chose to radially slice the 3D prostate image as opposed to transverse slicing in an attempt to improve segmentations at all boundaries. This choice was motivated by the experience of segmenting the prostate when the center of the gland is in-plane, which typically presents as an easier image to accurately define and segment the boundaries on the left and right sides of the 2D image. In contrast to this, a transverse slicing approach would result in 2D images with the prostate appearing as a different size and shape, with this difference more pronounced at the prostate apex and base, and when comparing end-fire and side-fire image geometries.’, [2.C Evaluation and comparison / pg. 2417 left col], ‘The performance of our algorithm was compared against three state-of-the-art fully 3D predicting CNNs (V-Net,24 Dense V-Net,25 and High-resolution 3D-Net26) using an open-source implementation on the NiftyNet platform.27 It is often assumed that performing a prediction based on 3D information allows for an improved result due to increased spatial context, so we completed a direct comparison on the same test dataset to investigate this hypothesis. Similar to our proposed method, the same 165/41 3D TRUS images (Table I) were used for training/validation, respectively. The 3D V-Net was chosen to optimize hyperparameters, including loss function, due to its widespread use and performance in preliminary experiments. For simplicity, these hyperparameters were also used for the Dense V-Net and high-resolution 3D-Net. Parameters were chosen to maximize the spatial window size and usable memory on the GPU with optimized hyperparameters shown in Table II. Previous work has shown improved performance with a hybrid loss function,16 so we compared performance between a dice loss function and a dice plus cross-entropy (DiceXEnt) loss function, as provided in NiftyNet, using the 3D V-Net. Although NiftyNet offers a patch-based analysis, preliminary experiments resulted in 3D segmentations with many flat surfaces throughout the prediction corresponding to patch edges. Since we had one structure of interest (i.e., the prostate), we did not perform a patch-based analysis and predictions were performed on a resized image to match the spatial window.’ In summary, Orlando teaches the 3D TRUS prostate image input (i.e., the region) and generations of the 3D prostate surface output (i.e., the contour). To represent these 3D structures, FIGS. 4-6 display cross-sectional image slices of the 3D ultrasound volume overlaid with boundary lines representing the 3D contour. Orlando teaches the 3D ultrasound region is displayed as a standard grayscale image, while the 3D contour boundaries, while the 3D contour boundaries are superimposed as distinctly colored lines, FIG. 4, pgs. 2420-2422. This different displaying manners (grayscale vs bright colors) allows the user viewing the results to separate and ascertain both the anatomical region and the boundary contours simultaneously. wherein the three-dimensional image data of the contour and the three-dimensional image data of the region are generated independently of each other. - the 3D image contour (i.e., boundary) is generated entirely independent of the 3D region data. These two data sets comes from the 3D region data acquired through ultrasound scanning of a patient, where the 3D contour data is generated either by manual human annotation, or computationally by the neural networks, see [2.A Clinical dataset / pg. 2415], [2.B.3. 3D Reconstruction / pg 2416], [2.C Evaluation and comparison / pg. 2417 left col]. It would have been obvious to one of ordinary skilled in the art before the effective filing date of the claimed invention to modify the monitor of Fujisawa to display to include an image representing a three-dimensional shape of the contour and an image representing a three-dimensional shape of the region in a superimposed manner and in different displaying manners, based on the three-dimensional image data of the contour and the three-dimensional image data of the region, wherein the three-dimensional image data of the contour and the three-dimensional image data of the region are generated independently of each other in view of the teachings of Orlando. The motivation to do this yield predictable results such as providing accurate targeting, reducing patient risk and improving clinical workflow as suggested by Orlando, ¶Abstract. Claim 3: Modified Fujisawa discloses all the elements above in claim 1, Fujisawa discloses, wherein the processor is configured to: determine a portion of which the contour is not depicted in the three-dimensional image data of the contour the organ or a portion of which the region is no -Fujisawa teaches that the system determines by the processor a portion of the organ where the contour or region is not detected, identifies this as a “unimaged region” or “data miss area” which aligns with a non-depicted portion, and then notifies the user about is presence, ¶Abstract, ¶0004, ¶0074-0075, ¶0082, ¶0095, ¶0097, ¶0108-0109, ¶0123, ¶0128-0129. Claim 5: Modified Fujisawa discloses all the elements above in claim 3, Fujisawa discloses, wherein the processor is configured to determine that a discontinuous portion having an interval equal to or greater than a predetermined interval in the region is the non-depicted portion. (¶0127, ‘The display control function 71 determines whether or not the ratio of the volume or contour of the unimaged organ region to the volume or contour of the entire organ shape derived in step ST15 is equal to or less than a threshold value (e.g. 20%). If it is determined as “YES” in step ST17, that is, if it is determined that the volume or contour ratio of the unimaged organ region is less than or equal to the threshold value, the display control function 71 displays on the display 20 that the data is sufficient with only a little missing data (step ST18).’, see also associated paragraphs, ¶0128-0129) Claim 6: Modified Fujisawa discloses all the elements above in claim 3, Fujisawa fails to disclose: wherein the processor is configured to: detect a noncontact state in which the ultrasound probe is separated from a body surface of the subject, based on whether an ultrasound image filled with one color is acquired; once determining the noncontact state, determine whether the non-depicted portion is present. (¶0105, ‘The acquiring function 171 determines whether to finish the ultrasonic imaging (step ST4). The acquiring function 171 may determine to finish the ultrasonic imaging on the basis of the finish instruction input by the operator via the input interface 19, or may determine that the ultrasonic imaging is finished if the ultrasonic probe 30 is in the air apart from the body surface of the subject after a certain time elapsed. For example, whether the ultrasonic probe 30 is in the air may be determined based on the position data of the ultrasonic probe 30.’) -Fig. 9, the system determines whether to finish ultrasonic imaging (step ST4), ¶0105. If imaging is determined to be finished (i.e. “YES”-ST4) then the deriving function 172 derives the organ shape and determines the unimaged organ region, ¶0105-0107. Therefore, if a predetermine period of time elapses and the probe is no longer in contact, the determination of the unimaged region occurs and thus an ultrasound image is not acquired. If there is no contact of the ultrasound probe the entire image would appear to be black or substantially black (i.e., one color). Claim 7: Modified Fujisawa discloses all the elements above in claim 3, Fujisawa discloses, wherein the processor is configured to, once a predetermined period of time has elapsed from a start of scanning by the ultrasound probe, determine whether the non-depicted portion is present. -Fig. 9, the system determines whether to finish ultrasonic imaging (step ST4), ¶0105. If imaging is determined to be finished (i.e. “YES”-ST4) then the deriving function 172 derives the organ shape and determines the unimaged organ region, ¶0105-0107. Therefore, if a predetermine period of time elapses and the probe is no longer in contact, the determination of the unimaged region occurs. Claim 8: Modified Fujisawa discloses all the elements above in claim 3, Fujisawa discloses, wherein the processor is configured to, once the user gives an instruction to complete an examination, determine whether the non-depicted portion is present. (¶0105, ‘The acquiring function 171 determines whether to finish the ultrasonic imaging (step ST4). The acquiring function 171 may determine to finish the ultrasonic imaging on the basis of the finish instruction input by the operator via the input interface 19, or may determine that the ultrasonic imaging is finished if the ultrasonic probe 30 is in the air apart from the body surface of the subject after a certain time elapsed. For example, whether the ultrasonic probe 30 is in the air may be determined based on the position data of the ultrasonic probe 30.’) -Fig. 9, the system determines whether to finish ultrasonic imaging (step ST4), ¶0105. If imaging is determined to be finished (i.e. “YES”-ST4) then the deriving function 172 derives the organ shape and determines the unimaged organ region, ¶0105-0107. Therefore, if a predetermine period of time elapses and the probe is no longer in contact, the determination of the unimaged region occurs. Claim 9: Modified Fujisawa discloses all the elements above in claim 3, Fujisawa discloses, wherein the processor is configured to, after the depicted contour forms a complete and successive shape, determine whether the non-depicted portion is present. (¶0107-0109) -FIG. 9, ST5-derive entire organ shape and imaged organ region. ST6, determine unimaged organ region. ST7 unimaged organ region exist “YES” or “NO”, Claim 10: Modified Fujisawa discloses all the elements above in claim 3, Fujisawa discloses, wherein the processor is configured to, after the depicted contour forms a complete and successive shape and the region that is not depicted becomes not present in a range inside the contour, notify the user that scanning is completed. (FIG. 12-ST1-ST3 & ST15-ST20, ¶0126-0131) -FIG. 12, ST15-derive entire organ shape and imaged organ region. ST16, determine unimaged organ region. ST17 unimaged organ region exist “YES” or “NO”,ST18 DISPLAY THAT DATA IS SUFFICIENT (this statement effectively serves as a notification to the user that the scanning has achieved a sufficient level of completeness). Claim 11: Modified Fujisawa discloses all the elements above in claim 5, Fujisawa discloses, the processor is configured to, after the depicted contour forms a complete and successive shape and the region that is not depicted becomes not present in a range inside the contour, notify the user that scanning is completed. (FIG. 12-ST1-ST3 & ST15-ST20, ¶0126-0131) -FIG. 12, ST15-derive entire organ shape and imaged organ region. ST16, determine unimaged organ region. ST17 unimaged organ region exist “YES” or “NO”,ST18 DISPLAY THAT DATA IS SUFFICIENT (this statement effectively serves as a notification to the user that the scanning has achieved a sufficient level of completeness). Claim 12: Modified Fujisawa discloses all the elements above in claim 6, Fujisawa fails to disclose: wherein the processor is configured to, once the depicted contour is closed and the region that is not depicted is not present in a range inside the contour, notify the user that scanning is completed. (FIG. 12-ST1-ST3 & ST15-ST20, ¶0126-0131) -FIG. 12, ST15-derive entire organ shape and imaged organ region. ST16, determine unimaged organ region. ST17 unimaged organ region exist “YES” or “NO”,ST18 DISPLAY THAT DATA IS SUFFICIENT (this statement effectively serves as a notification to the user that the scanning has achieved a sufficient level of completeness). Claim 13: Modified Fujisawa discloses all the elements above in claim 1, Fujisawa discloses, wherein the processor is configured to: display a three-dimensional schema image on the monitor; and display the contour and the region in an emphasized manner on the three-dimensional schema image. (¶0042, ¶0108) Claim 14: Modified Fujisawa discloses all the elements above in claim 3, Fujisawa discloses, comprising: a reference contour memory configured to store a reference contour that is able to be depicted, wherein the processor is configured to, once that the contour corresponding to the reference contour stored in the reference contour memory is not depicted, notify the user to move the ultrasound probe. -The system of Fujisawa utilizes a “3D model of the entire organ” which acts as a reference contour. This 3D model can be pre-acquired or be a general organ shape, ¶0108. This 3D model is stored in the main memory 18, which work in concert with the image memory 15, ¶0041-0042, ¶0047, ¶0106-0108. The determining function 173 address the non-depicted portion by “extracts an organ contour from the ultrasonic image of cross-sections arranged three-dimensionally” and then “collates the arranged one with a 3D model of the entire organ”, ¶0108. Subsequently, it “determines, as an unimaged organ region, a region acquired by removing the organ contour included in the already existing data area from the organ contour of the 3D model.”, ¶0108. This unimaged organ region is the portion of the reference contour that has no been detected or depicted by the probe’s scanning. If the determination function 173 determines that an unimaged organ is present, “YES” in step ST, the display, “displays information regarding the unimaged organ region on the display, ¶0109. This information is used by the operator to image the missing area, by moving the ultrasonic probe to the indicated positions and orientations of the unimaged region, ¶0119-0120. Claim 15: Modified Fujisawa discloses all the elements above in claim 1, Fujisawa discloses, wherein the processor is configured to display, on the monitor, the three-dimensional image of the contour and the three-dimensional image of the region, as the image representing the contour and the image representing the region. -Based on the 35 USC § 112(b), the phrase is interpreted as display on the monitor a three-dimensional image representing the contour and region (i.e., one image) based on the image of the contour and the region. -Fujisawa teaches 3D image data, ¶0040-0042, displaying the 3D of the entire organ and unimaged region, ¶0108, ¶0112-0115. The system effectively uses and display a 3D schema (the 3D model of the entire organ and thus region) and overlays information about the detected and undetected (unimaged) region directly onto this 3D representation to guide the user, ¶0109, ¶0112-0122. Claim 17: Modified Fujisawa discloses all the elements above in claim 1, Fujisawa discloses, wherein the processor is configured to display the image representing the contour and the image representing the region in a superimposed manner on the monitor. -Fujisawa discloses displaying the image of the contour and the image of the region in a superimposed manner, ¶0108-0109, ¶0112-0122. Specifically, Fujisawa indicates that the detected unimaged region, the suggested beam range to fill it, and guidance of probe placement are represented visually on the 3D model of the organ, thereby superimposing this information. Claim 19: Fujisawa discloses all the elements above in claim 1, Fujisawa discloses, wherein the position and posture sensor includes an inertial sensor, a magnetic sensor, or an optical sensor. (¶0055) Claim 20: Fujisawa discloses, A control method of an ultrasound diagnostic apparatus, (FIG. 3, FIG. 9, FIG. 12) the control method comprising: acquiring position and posture information of an ultrasound probe; (position sensor 40, FIG. 3, ¶0053) acquiring a plurality of ultrasound images of a subject by transmitting and receiving ultrasound beams by using the ultrasound probe; (¶Abstract, ¶0026-0027, ¶0077) generating three-dimensional image data of a contour of an organ included in each of the plurality of ultrasound images based on the acquired position and posture information; generating three-dimensional image data of a region of the organ included in each of the plurality of ultrasound images based on the acquired position and posture information; and -The ultrasonic image data, in the form of multiple cross-sections, correspond to position data of the ultrasonic probe, ¶0061-0063, ¶0103-0104. This positional data includes the coordinates (X, Y, Z) and tilt angle (posture) of the probe, ¶0054. The acquired ultrasonic image is arranged three-dimensionally in a 3D memory based on the position data, ¶0078-0080, ¶0103-0104. From this collection of three-dimensionally arrange ultrasonic image data and position data, deriving function 172 determines the shape of the entire target organ and the imaged organ region, ¶0076-0077, ¶0082, ¶0107. The determining function 172 specifically extracts an organ contour from the ultrasonic image of cross-sections arranged three-dimensionally, ¶0108. This extracted organ contour is then arranged in a three-dimensional manner, ¶0108, and thus the region of the organ is arranged in a three-dimensional manner. This volume data of the 3D image data represents the imaged organ region in three-dimensions, ¶0076-0077, ¶0082, ¶0107. Fujisawa fails to disclose: displaying, on a monitor, a first image representing a three-dimensional shape of the contour and a second image representing a three-dimensional shape of the region in different displaying manners such that a user can ascertain both the first image and the second image, based on the three-dimensional image data of the contour and the three-dimensional image data of the region, wherein the three-dimensional image data of the contour and the three-dimensional image data of the region are generated independently of each other. However, Orlando in the context of segmentation techniques using deep learning on ultrasound images discloses, displaying, on a monitor, a first image representing a three-dimensional shape of the contour and a second image representing a three-dimensional shape of the region in different displaying manners such that a user can ascertain both the first image and the second image, based on the three-dimensional image data of the contour and the three-dimensional image data of the region, -Regarding the region, Orlando teaches 3D TRUS images serving as the 3D region data acquired from the patient, [2.A Clinical dataset / pg. 2415], ‘Three-dimensional images of the prostate were acquired using end-fire (as used in prostate biopsy) and side-fire SR (as used in some HDR-BT) mechanical scanning approaches (Fig. 1).19 Both methods rotate a TRUS transducer around the long-axis to create geometrically different reconstructed 3D images that are influenced by the transducer array configuration. The images used in this study were acquired with the C9-5 transducer with the iU22 (Philips, Amsterdam, the Netherlands), the C9-5 and BPTRT9-5 transducers with the ATL HDI-5000 (Philips, Amsterdam, the Netherlands), and the 8848 transducer with the Profocus 2202 (BK Medical, Peabody, MA, USA) ultrasound machine models. The total dataset of 246 3D TRUS images consisted of 104 end-fire and 142 side-fire 3D TRUS images and was split into training, validation, and testing datasets as shown in Table I. Manual 3D prostate segmentations (excluding the seminal vesicles) were performed by an observer (IG) with approximately 15 yr of TRUS prostate image analysis experience.’ -Regarding the 3D image contour (i.e., boundary) is generated entirely independent of the raw region data. It is generated manually by an observer with 15 years of experience or computationally via deep learning, such as U-Net or 3D V-NET, see [2.A Clinical dataset / pg. 2415], [2.B.3. 3D Reconstruction / pg 2416], ‘2.B.3 3D Reconstruction Predicted 3D prostate segmentations were obtained by segmenting multiple 2D radial frames generated by rotation around a central axis, followed by reconstruction to a 3D surface following a reconstruction method similar to Qiu et al.11 Previous observations have noted that segmenting the prostate on slices near the apex and base of the prostate can be challenging due to boundary incompleteness,15 so we chose to radially slice the 3D prostate image as opposed to transverse slicing in an attempt to improve segmentations at all boundaries. This choice was motivated by the experience of segmenting the prostate when the center of the gland is in-plane, which typically presents as an easier image to accurately define and segment the boundaries on the left and right sides of the 2D image. In contrast to this, a transverse slicing approach would result in 2D images with the prostate appearing as a different size and shape, with this difference more pronounced at the prostate apex and base, and when comparing end-fire and side-fire image geometries.’, [2.C Evaluation and comparison / pg. 2417 left col], ‘The performance of our algorithm was compared against three state-of-the-art fully 3D predicting CNNs (V-Net,24 Dense V-Net,25 and High-resolution 3D-Net26) using an open-source implementation on the NiftyNet platform.27 It is often assumed that performing a prediction based on 3D information allows for an improved result due to increased spatial context, so we completed a direct comparison on the same test dataset to investigate this hypothesis. Similar to our proposed method, the same 165/41 3D TRUS images (Table I) were used for training/validation, respectively. The 3D V-Net was chosen to optimize hyperparameters, including loss function, due to its widespread use and performance in preliminary experiments. For simplicity, these hyperparameters were also used for the Dense V-Net and high-resolution 3D-Net. Parameters were chosen to maximize the spatial window size and usable memory on the GPU with optimized hyperparameters shown in Table II. Previous work has shown improved performance with a hybrid loss function,16 so we compared performance between a dice loss function and a dice plus cross-entropy (DiceXEnt) loss function, as provided in NiftyNet, using the 3D V-Net. Although NiftyNet offers a patch-based analysis, preliminary experiments resulted in 3D segmentations with many flat surfaces throughout the prediction corresponding to patch edges. Since we had one structure of interest (i.e., the prostate), we did not perform a patch-based analysis and predictions were performed on a resized image to match the spatial window.’ In summary, Orlando teaches the 3D TRUS prostate image input (i.e., the region) and generations of the 3D prostate surface output (i.e., the contour). To represent these 3D structures, FIGS. 4-6 display cross-sectional image slices of the 3D ultrasound volume overlaid with boundary lines representing the 3D contour. Orlando teaches the 3D ultrasound region is displayed as a standard grayscale image, while the 3D contour boundaries, while the 3D contour boundaries are superimposed as distinctly colored lines, FIG. 4, pgs. 2420-2422. This different displaying manners (grayscale vs bright colors) allows the user viewing the results to separate and ascertain both the anatomical region and the boundary contours simultaneously. wherein the three-dimensional image data of the contour and the three-dimensional image data of the region are generated independently of each other. - the 3D image contour (i.e., boundary) is generated entirely independent of the 3D region data. These two data sets comes from the 3D region data acquired through ultrasound scanning of a patient, where the 3D contour data is generated either by manual human annotation, or computationally by the neural networks, see [2.A Clinical dataset / pg. 2415], [2.B.3. 3D Reconstruction / pg 2416], [2.C Evaluation and comparison / pg. 2417 left col]. It would have been obvious to one of ordinary skilled in the art before the effective filing date of the claimed invention to modify the monitor of Fujisawa to display to include an image representing a three-dimensional shape of the contour and an image representing a three-dimensional shape of the region in a superimposed manner and in different displaying manners, based on the three-dimensional image data of the contour and the three-dimensional image data of the region, wherein the three-dimensional image data of the contour and the three-dimensional image data of the region are generated independently of each other in view of the teachings of Orlando. The motivation to do this yield predictable results such as providing accurate targeting, reducing patient risk and improving clinical workflow as suggested by Orlando, ¶Abstract. Claim 16 is rejected under 35 U.S.C. 103 as being unpatentable over Fujisawa (US 2021/0093303 A1) in view of Orlando et al (Automatic prostate segmentation using deep learning on clinically diverse 3D transrectal ultrasound images. Med Phys. 2020 Jun), as applied to claim 1, in further view of Fukuda et al (US 20170252000 A1). Claim 16: Modified Fujisawa discloses all the elements above in claim 1, Fujisawa discloses, extracting 2D images from 3D data for a 2D display, ¶0042, ‘in order to generate various 2D image data so as to display the volume data stored in the 3D memory on the display 20, the image generating circuit 14 performs processing for displaying the volume data on the 2D display and processing for displaying the 3D data three-dimensionally, with respect to the volume data.’. Fujisawa fails to explicitly disclose: wherein the processor is configured to: extract a two-dimensional tomographic image of the contour and a two-dimensional tomographic image of the region on a same cut section, from the three-dimensional image data of the contour and the three-dimensional image data of the region, respectively; and display, on the monitor, the two-dimensional tomographic image of the contour and the two-dimensional tomographic image of the region, as the image representing the contour and the image representing the region. However, Fukuda in the context of the known function of three-dimensional segmentation, discloses, extract a two-dimensional tomographic image of the contour and a two-dimensional tomographic image of the region on a same cut section, from the three-dimensional image data of the contour and the three-dimensional image data of the region, respectively; and -The ultrasound apparatus performs 3D scanning to acquire 3D signals to generate 3D voltage data which includes the heart of the subject, ¶0021, ¶0024-0025, ¶0033, ¶0057-0058, Claim 14. The image generating circuitry 141 generates multi-planar reconstruction (MPR) images from the voltage data, ¶0038-0039. MPR is a technique for producing 2D images (tomographic images) from 3D data, ¶0038-0039, ¶0073, ¶0077, ¶0097. Volume data corresponding to selected regions are generated by the image generation circuitry 141 which constructs cross-sectional images by MPR from each of the selected volume data, ¶0038-0039, ¶0073, ¶0077, ¶0097. The control function 140a then causes the display 103 to display these generated cross-sectional images, ¶0073. The identification function 170b automatically traces and identifies the 3D contour of the heart for each selected volume data, ¶0076, ¶0092. Alternatively, when 3D scanning is performed, the identification function 170b generates a plurality of cross sectional images by MPR processing from the volume data and then identify the contour of the LV of the heart for each of the cross-sectional images, ¶0077, ¶0097. This means the contour is identified on the already generated two-dimensional tomographic image of the region, ensuring its one the “same cut section”, respectively. display, on the monitor, the two-dimensional tomographic image of the contour and the two-dimensional tomographic image of the region, as the image representing the contour and the image representing the region. -Fukuda teaches from 3D volume data, 2D tomographic images of the heart region can be generated using MPR. Subsequently, the contour is either identified directly from the three dimensions and information used, or more commonly, the contour is identified on these generated two-dimensional tomographic images, ¶0077, ¶0097. An “image” or representation of this contour is then displayed directly on that same two-dimensional tomographic image of the region, allowing for simultaneous visualization of both on the same “cut section”, ¶0112-0116. It would have been obvious to one of ordinary skilled in the art before the effective filing date of the claimed invention to modify the processor of modified Fujisawa to include, extracting a two-dimensional tomographic image of the contour and a two-dimensional tomographic image of the region on a same cut section, from the three-dimensional image data of the contour and the three-dimensional image data of the region, respectively; and displaying, on the monitor, the two-dimensional tomographic image of the contour and the two-dimensional tomographic image of the region, as the image representing the contour and the image representing the region as taught by Fukuda. The motivation to do this yields predictable results such as assisting a user in easily performing diagnosis of the organ by providing useful information about the shape and position of the contour, ¶0114-0116 of Fukuda. Claim 18 is rejected under 35 U.S.C. 103 as being unpatentable over Fujisawa (US 2021/0093303 A1) in view of Orlando et al (Automatic prostate segmentation using deep learning on clinically diverse 3D transrectal ultrasound images. Med Phys. 2020 Jun), as applied to claim 1, in further view of Gooding et al (US 2023/0100255 A1). Claim 18: Modified Fujisawa discloses all the elements above in claim 1, Fujisawa fails to disclose: wherein the processor is configured to display the image representing the contour and the image representing the region side by side on the monitor. However, Gooding in the context of interacting contouring of medical images discloses, wherein the processor is configured to display the image representing the contour and the image representing the region side by side on the monitor. (FIG. 6, ¶0105, ¶0146, ¶0156) It would have been obvious to one of ordinary skilled in the art before the effective filing date of the claimed invention to modify the processor of modified Fujisawa to be configured to display the image representing the contour and the image representing the region side by side on the monitor as taught by Gooding. The motivation to do this yields predictable results such as improving spatial and imaging context to the user. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Schoisswohl et al (US 2006/0056690 A1) discloses methods for 3D segmentation of ultrasound images to 2D images of contours and regions of interest, ¶Abstract. Raynaud et al (US 2025/0134493 A1) discloses detecting missing regions and contours in image segmentation techniques, ¶Abstract, ¶0020, ¶0025-0026. Altmann et al (US 2006/0241445 A1) discloses cardiac imaging using ultrasound contour reconstruction. Zur et al (US 2009/0080738 A1) disclose edge detection in ultrasound imaging with respect to closed contours of a region of interest. Miseikis (US 2025/0072862 A1) discloses reconstructing of missing portions of a fetus by generative AI. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Nicholas Robinson whose telephone number is (571)272-9019. The examiner can normally be reached M-F 9:00AM-5:00PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Pascal Bui-Pho can be reached at (571) 272-2714. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /N.A.R./Examiner, Art Unit 3798 /PASCAL M BUI PHO/Supervisory Patent Examiner, Art Unit 3798
Read full office action

Prosecution Timeline

Show 4 earlier events
Oct 24, 2025
Applicant Interview (Telephonic)
Nov 13, 2025
Response Filed
Mar 23, 2026
Final Rejection mailed — §103, §112
May 26, 2026
Response after Non-Final Action
Jun 03, 2026
Request for Continued Examination
Jun 10, 2026
Response after Non-Final Action
Jun 10, 2026
Non-Final Rejection (signed) — §103, §112
Jul 15, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12697016
IMAGING SYSTEM WITH OPTICAL PATHWAY
1y 5m to grant Granted Aug 04, 2026
Patent 12678081
SYSTEMS AND METHODS FOR DETECTION OF NEUROPHYSIOLOGICAL SIGNAL OSCILLATIONS
3y 3m to grant Granted Jul 14, 2026
Patent 12673223
ULTRASOUND STIMULATION OF MUSCULO-SKELETAL TISSUE STRUCTURES
4y 11m to grant Granted Jul 07, 2026
Patent 12650480
RADIO FREQUENCY RECEIVING COIL ASSEMBLY WITH HANDLE
3y 11m to grant Granted Jun 09, 2026
Patent 12642590
Technique For Determining A Visualization Based On An Estimated Surgeon Pose
3y 1m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
49%
Grant Probability
99%
With Interview (+58.2%)
3y 6m (~1y 6m remaining)
Median Time to Grant
High
PTA Risk
Based on 146 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month